ÇмúÇà»ç

Korean Society of Gastrointestinal Cancer Research

Çмú´ëȸ ÀÚ·á½Ç

Á¦ 2ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾ö 2006

¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ °­´ç 2006-09-09

Á¦ 2ȸ ´ëÇѼÒÈ­±âÇ׾Ͽ¬±¸È¸ ½ÉÆ÷Áö¾ö 2006
(Session I) 09:05-10:35 Comprehension of Chemotherapeutic Agents for GI Cancer ÁÂÀå : À±¿ë¹ü, ÃÖ¼®·Ä
09:05-09:25 Conventional Chemotherapeutic Agents ±¹¸³¾Ï¼¾ÅÍ ÀÌ¿ìÁø ¼±»ý´Ô
09:30-09:50 Emerging New CHemotherapeutic Agents °í½Å´ë ¹Ú¼±ÀÚ ¼±»ý´Ô
09:55-10:10 Oral Anticancer Agents ¼­¿ï´ë ·ùÁö°ï ¼±»ý´Ô
10:15-10:30 Humanized Monoclonal Antibody Treatment ¿¬¼¼´ë ¹æ½Â¹Î ¼±»ý´Ô
(Session II) 10:55-12:10 Management of Complication in Anti-Cancer Treatment ÁÂÀå : ±èâ´ö, ¾çâÇå
10:55-11:15 GI related complications °¡Å縯´ë ±è»ó¿ì ¼±»ý´Ô
11:20-11:40 Hematological Complications °¡Å縯´ë À̼® ¼±»ý´Ô
11:45-12:05 Dose modification in Comorbid Illness ´ë±¸ °¡Å縯´ë Á¤ÁøÅ ¼±»ý´Ô
12:10-13:10 Lunch
13:10-13:40 Special Lecture ÁÂÀå : ÃÖ¿ëȯ
Experience of Anti-cancer Treatment for GI Cancer in Japan Tohoku University Makaoto Sunamura
13:40-14:00 Coffee Break
(Session III) 14:00-15:50 ¼ÒÈ­±â¾Ï¿¡¼­ÀÇ ¼ÒÈ­±â Àü°øÀÇ»çÀÇ ¿ªÇÒ ÁÂÀå : À帰, ¼Û½Ã¿µ
14:00-14:15 À§Àå°ü¾Ï¿¡¼­ÀÇ ¿ªÇÒ ±èÀ籤 ¼±»ý´Ô
14:20-14:35 °£´ãÃéÀå¾Ï¿¡¼­ÀÇ ¿ªÇÒ ÀÌÈ«½Ä ¼±»ý´Ô
14:40-14:55 ¼ÒÈ­±â³»°ú Ç×¾Ï Ä¡·áÀÇ ±¹³» ÇöȲ ¹Ú½Â¿ì ¼±»ý´Ô
15:00-15:20 Ç×¾ÏÈ­Çпä¹ý °ø°í¾È°ú ¾ÏÁúȯ ½ÉÀÇÀ§¿øȸÀÇ ¿ªÇÒ ÀÌ»ó¹« ¼±»ý´Ô
15:20-15:50 ÆгÎÅäÀÇ
15:50- Closing Remark